Deepak L. Bhatt, MD, MPH, MBA
Deepak L. Bhatt, MD, MPH, MBA
Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai
Verified email at - Homepage
Cited by
Cited by
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
Heart disease and stroke statistics 2005 update
American Heart Association
http://www. americanheart. org/statistics/, 2005
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ...
Circulation 123 (23), 2736-2747, 2011
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ...
New England Journal of Medicine 369 (14), 1317-1326, 2013
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical …
HP Adams Jr, G Del Zoppo, MJ Alberts, DL Bhatt, L Brass, A Furlan, ...
Stroke 38 (5), 1655-1711, 2007
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ...
New England Journal of Medicine 354 (16), 1706-1717, 2006
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ...
New England Journal of Medicine 380 (1), 11-22, 2019
Bariatric surgery versus intensive medical therapy in obese patients with diabetes
PR Schauer, SR Kashyap, K Wolski, SA Brethauer, JP Kirwan, CE Pothier, ...
New England Journal of Medicine 366 (17), 1567-1576, 2012
Alirocumab and cardiovascular outcomes after acute coronary syndrome
GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ...
New England Journal of Medicine 379 (22), 2097-2107, 2018
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome …
TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ...
The Lancet 393 (10166), 31-39, 2019
Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes
PR Schauer, DL Bhatt, JP Kirwan, K Wolski, A Aminian, SA Brethauer, ...
New England Journal of Medicine 376 (7), 641-651, 2017
A controlled trial of renal denervation for resistant hypertension
DL Bhatt, DE Kandzari, WW O'Neill, R D'Agostino, JM Flack, BT Katzen, ...
New England Journal of Medicine 370 (15), 1393-1401, 2014
Rivaroxaban in patients with a recent acute coronary syndrome
JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ...
New England Journal of Medicine 366 (1), 9-19, 2012
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology …
SD Fihn, JM Gardin, J Abrams, K Berra, JC Blankenship, AP Dallas, ...
Journal of the American College of Cardiology 60 (24), e44-e164, 2012
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda, JL Mas, S Goto, ...
Jama 295 (2), 180-189, 2006
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American …
JS Skyler, R Bergenstal, RO Bonow, J Buse, P Deedwania, EAM Gale, ...
Circulation 119 (2), 351-357, 2009
One-year cardiovascular event rates in outpatients with atherothrombosis
PG Steg, DL Bhatt, PWF Wilson, R D’Agostino, EM Ohman, J Röther, ...
Jama 297 (11), 1197-1206, 2007
The system can't perform the operation now. Try again later.
Articles 1–20